Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production

Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β productionCombination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production, Published online: 07 February 2018; doi:10.1038/s41419-017-0194-1Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production

Source: Cell death and disease - February 7, 2018 Category: Internal Medicine Authors: Anthony C Tang Seyed M Rahavi Shan-Yu Fung Henry Y Lu Hong Yang Chinten J Lim Gregor S Reid Stuart E Turvey Source Type: research